Formulation of an antispasmodic drug as a topical local anesthetic

International Journal of Pharmaceutics

Volumn 326, Issue 1-2, 2006, Pages 107-118

  Abdel Hamid, Sameh M ^a   Abdel Hady, S E ^a   El Shamy, A A ^a   El Dessouky, H F ^b  

^a Ain Shams University   (Egypt)

^b Ain Shams University   (Egypt)

Author keywords

Gel; Histopathology; Local anesthetic; Mebeverine HCl; Oral painful conditions

Indexed keywords

CETRIMIDE; HYDROXYPROPYLCELLULOSE; LIDOCAINE; MEBEVERINE; POLOXAMER; SPASMOLYTIC AGENT;

ANALGESIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; DRUG FORMULATION; DRUG RELEASE; HISTOPATHOLOGY; INFLAMMATORY CELL; LOCAL ANESTHESIA; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANESTHETICS, LOCAL; ANIMALS; CELLULOSE; CETRIMONIUM COMPOUNDS; CHEMISTRY, PHARMACEUTICAL; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; MOUTH MUCOSA; PARASYMPATHOLYTICS; PHENETHYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; TECHNOLOGY, PHARMACEUTICAL;

EID: 33751051538     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.07.028     Document Type: Article

References (72)

1. Abdel-Hady S.S., Mortada N.D., Awad G.A.S., Zaki N.M., and Taha R.A. Development of in situ gelling and mucoadhesive mebeverine hydrochloride solution for rectal administration. Saudi Pharm. J. 11 (2003) 159-171
2. Amir H.S. Buccal mucosa as a route for systemic drug delivery: a review. J. Pharm. Pharm. Sci. 1 (1998) 15-30
3. Amsden B. Solute diffusion with hydrogels, mechanisms and models. Macromolecules 31 (1998) 8382-8395
4. Aungst B.J., and Rogers N.J. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int. J. Pharm. 53 (1989) 227-235
5. Barreiro-Iglesias R., Alvarez-Lorenzo C., and Concheiro A. Incorporation of small quantities of surfactants as a way to improve the rheological and diffusional behavior of carbopol gels. J. Control. Release 77 (2001) 59-75
6. Bhardwaj R., and Blanchard J. Controlled-release delivery system for the α-MSH analog Melanotan-I using Poloxamer 407. J. Pharm. Sci. 85 (1996) 915-919
7. Bromberg L., Temchenko M., Alakhov V., and Hatton T.A. Bioadhesive properties and rheology of polyether-modified poly(acrylic acid) hydrogels. Int. J. Pharm. 282 (2004) 45-60
8. Buckton G., and Tawburic S. Drug release from gel bases: a case for enthalpy-entropy compensation. J. Control. Release 20 (1992) 29-36
9. Ch'ng H.S., Park H., Kelly P., and Robinson J.R. Bioadhesive polymers as platforms for oral controlled drug delivery. Part 2. Synthesis and evaluation of some swelling, water insoluble bioadhesive polymers. J. Pharm. Sci. 74 (1985) 399-411
10. Choi H.-G., Jung J.-H., Ryu J.-M., Yoon S.-J., Oh Y.-K., and Kim C.-K. Development of in situ gelling and mucoadhesive acetaminophen liquid suppository. Int. J. Pharm. 165 (1998) 33-44
11. Connell A.M. Physiological and clinical assessment of the effect of the musculotropic agent mebeverine on the human colon. Br. Med. J. 2 (1965) 848-851
12. Czechowicz S., McCulloch M.W., Raper C., and Rand M.J. The mode of action of mebeverine, a spasmolytic agent. Pharmacol. Res. Commun. 1 (1969) 303-309
13. Den Hertog A., and Van den Akker J. The action of mebeverine on mammalian non-myelinated nerve fibres. Eur. J. Pharmacol. 139 (1987) 353-355
14. Desai S.D., and Blanchard J. In vitro evaluation of pluronic F-127 based controlled release ocular delivery systems for Pilocarpine. J. Pharm. Sci. 87 (1998) 226-230
15. Desai K.G.H., and Kumar T.M.P. Preparation and evaluation of a novel buccal adhesive system. AAPS Pharm. Sci. Technol. 5 (2004) (article 35)
16. DiBiase M.D., and Rhodes C.T. Formulation and evaluation of epidermal growth factor in pluronic F-127 gel. Drug Develop. Ind. Pharm. 22 (1996) 823-831
17. Dickinson R.G., Baker P.V., Franklin M.E., and Hooper W.D. Facile hydrolysis of mebeverine in vitro and in vivo: negligible circulating concentrations of the drug after oral administration. J. Pharm. Sci. 80 (1991) 952-957
18. Eouani C., Piccerellea P., Prinderrea P., Bourret E., and Joachim J. In vitro comparative study of buccal mucoadhesive performance of different polymeric films. Eur. J. Pharm. Biopharm. 52 (2001) 45-55
19. Esposito E., Carotta V., Scabbia A., Trombelli L., Antona P.D., Menegatti E., and Nastruzzi C. Comparative analysis of tetracycline-containing dental gels: poloxamer- and monoglyceride-based formulations. Int. J. Pharm. 142 (1996) 9-23
20. Friskopp J., Nilsson M., and Isacsson G. The anesthetic onset and duration of a new lidocaine/prilocaine gel intra-pocket anesthetic (Oraquix) for periodontal scaling/root planning. J. Clin. Periodontol. 28 (2001) 453-458
21. Gallagher S.J., Trottet L., and Heard C.M. Ketoprofen: release from, permeation across and rheology of simple gel formulations that simulate increasing dryness. Int. J. Pharm. 268 (2003) 37-45
22. Gilbody J.S., Fletcher C.P., Hughes I.W., and Kidman S.P. Comparison of two different formulations of mebeverine hydrochloride in irritable bowel syndrome. Int. J. Clin. Pract. 54 (2000) 461-464
23. Gurny R., Meyer J.M., and Peppas N.A. Bioadhesive intraoral release systems: design, testing and analysis. Biomaterials 5 (1984) 336-340
24. Guzman M., Garcia F.F., Molpeceres J., and Aberturas M.R. Polyoxyethylene-polyoxypropylene block copolymer gels as sustained release vehicles for subcutaneous drug administration. Int. J. Pharm. 80 (1992) 119-127
25. Hägerström H., and Edsman K. Limitations of the rheological mucoadhesion method: the effect of the choice of conditions and the rheological synergism parameter. Eur. J. Pharm. Sci. 18 (2003) 349-357
26. Hansson P., and Lindman B. Surfactant-polymer interactions. Curr. Opin. Colloid Interf. Sci. 1 (1996) 604-613
27. Huang K., Lee B.P., Ingram D.R., and Messersmith P.B. Synthesis and characterization of self-assembling block copolymers containing bioadhesive end groups. Biomacromolecules 3 (2002) 397-406
28. Ikinci G., Capan Y., Şenel S., Alaaddinoglu E., Dalkara T., and Hincal A.A. In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine. Pharmazie 55 (2000) 762-765
29. Inauen W., and Halter F. Clinical efficacy, safety and tolerance of mebeverine slow-release (200 mg) versus mebeverine tablets in patients with irritable bowel syndrome. Drug Invest. 8 (1994) 234-240
30. Irwin C.R., McCullough K.C., and Jones D.S. Chlorhexidine-containing mucoadhesive polymeric compacts designed for use in the oral cavity: an examination of their physical properties, in vitro/in vivo drug release properties and clinical acceptability. Mater. Sci. Mater. Med. 14 (2003) 825-832
31. Jacox, A., Carr, D.B., Payne, R., 1994. Clinical Practice Guideline number 9: Management of cancer pain, AHCPR publication 94-0592. US Department of Health and Human Services, Agency for Health Care Policy and Research, Rockville, MD.
32. Jensen M.P., Turner J.A., and Romano J.M. Chronic pain copying measures: individuals versus composite scores. Pain 51 (1992) 273-280
33. Jimenez-Castellanos M., Zia H., and Rhodes C.T. Mucoadhesive drug delivery systems. Drug Develop. Ind. Pharm. 19 (1993) 143-194
34. Jones D.S., Woolfson A.D., Djokic J., and Coulter W.A. Development and mechanical characterization of bioadhesive semi-solid polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm. Res. 13 (1996) 1732-1736
35. Jones D.S., Woolfson A.D., and Brown A.F. Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int. J. Pharm. 151 (1997) 223-233
36. Jones D.S., Woolfson A.D., and Brown A.F. Textural analysis and flow rheometry of bioadhesive, antimicrobial oral gels. Pharm. Res. 14 (1997) 450-457
37. Jones D.S., Woolfson A.D., Brown A.F., Coulter W.A., McClelland C., and Irwin C.R. Design, characterization and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. J. Control. Release 67 (2000) 357-368
38. Kibbe A.H. Handbook of Pharmaceutical Excipients. 3rd ed. (2000), Pharmaceutical Association and Pharmaceutical Press, London, United Kingdom pp. 140-142
39. Kitagawa N., Kaminoh Y., Takasaki M., and Ueda I. Use of ion-exchange membranes to measure transfer free energies of charged local anesthetics: correlation to anesthetic potency. J. Pharm. Sci. 79 (1990) 344-348
40. Klech C.M. Gels and jellies. In: Swarbrick J., and Boylan J.C. (Eds). Encyclopedia of Pharmaceutical Technology vol. 6 (1999), Marcel Dekker Inc., New York, Basel 415-439
41. Kumar S., Haglund B.O., and Himmelstein K.J. In situ-forming gels for ophthalmic drug delivery. J. Ocul. Pharmacol. 10 (1994) 47-56
42. Laba D. Rheological Properties of Cosmetics and Toiletries (1993), Marcel Dekker, New York p. 19
43. Langrick A.F., Gunn A.D.G., Livesey H., and Whitehead A.M. A double-blind placebo-controlled crossover study of mebeverine and mefenamic acid in the treatment of primary dysmenorrhea. Br. J. Clin. Pract. 43 (1989) 317-321
44. Lipari J.M., and Reiland T.L. Flavors and flavor modifiers. In: Swarbrick J., and Boylan J.C. (Eds). Encyclopedia of Pharmaceutical Technology. 2nd ed. vol. 2 (2002), Marcel Dekker Inc., New York, Basel 1254-1263
45. Miller S.C., and Drabik B.R. The rheological properties of poloxamer vehicles. Int. J. Pharm. 18 (1984) 269-276
46. Mitchell K., Ford J.L., Armsrtong D.J., Eliott P.N.C., Rostron C., and Hogan J.E. The influence of additives on the cloud point, disintegration and dissolution of hydroxypropylmethylcellulose gels and matrix tablets. Int. J. Pharm. 66 (1990) 233-242
47. Nagai T., and Konishi R. Buccal/gingival drug delivery systems. J. Control. Release 6 (1987) 353-360
48. Nairn J.G. Solutions, emulsions, suspensions and extracts. In: Gennaro A.R. (Ed). Remington: The Science and Practice of Pharmacy. 20th ed. (2000), Williams and Wilkins Inc., Lippincott, Philadelphia 745-747 (Chapter 39)
49. Nalbandian R.M., Henry R.L., Balko K.W., Adams D.V., and Neuman N.R. Pluronic F-127 gel preparation as an artificial skin in the treatment of third-degree burns in pigs. J. Biomed. Mater. Res. 21 (1987) 1135-1148
50. O'Hara T., Dunne A., Butler J., and Devane J. A review of methods used to compare dissolution profile data. PSTT 1 (1998) 214-223
51. Paavola A., Tarkkila P., Xu M., Wahlström T., Yliruusi J., and Rosenberg P. Controlled-release gel of ibuprofen and lidocaine in epidural use-analgesia and systemic absorption in pigs. Pharm. Res. 15 (1998) 482-487
52. Park K., and Robinson J.R. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int. J. Pharm. 19 (1984) 107-127
53. Peh K.K., and Wong C.F. Polymeric films as a vehicle for buccal delivery: swelling, mechanical and bioadhesive properties. J. Pharm. Sci. 2 (1999) 53-61
54. Pena L.E., Lee B.L., and Sterns J.F. Structural rheology of model ointment. Pharm. Res. 11 (1994) 875-881
55. Peppas N.A. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60 (1985) 110-111
56. Perioli L., Ambrogi V., Angelici F., Ricci M., Giovagnoli S., Capuccella M., and Rossi C. Development of mucoadhesive patches for buccal administration of ibuprofen. J. Control. Release 99 (2004) 73-82
57. Primosch R.E., and Rolland-Asensi G. Comparison of topical EMLA 5% oral adhesive to benzocaine 20% on the pain experienced during palatal anesthetic infiltration in children. Pediatr. Dent. 23 (2001) 11-14
58. Radwan M.A., Foda N.H., and Al-Deeb O.A. Mebeverine hydrochloride. In: Britain H.G. (Ed). Analytical Profiles of Drug Substances and Excipients vol. 25 (1998), Academic Press, California 165-205
59. Ramachandran S., Chen S., and Etzler F. Rheological characterization of hydroxypropylcellulose gels. Drug Develop. Ind. Pharm. 25 (1999) 153-161
60. Ritchie J.A., and Truelove S.C. Comparison of various treatments for irritable bowel syndrome. Br. Med. J. 231 (1980) 1317-1319
61. Scherlund M., Brodin A., and Malmesten M. Non-ionic cellulose ethers as potential drug delivery systems for periodontal anesthesia. J. Colloid Interf. Sci. 229 (2000) 365-374
62. Şenel S., Capan Y., Sargon M.F., Giray C.B., and Hincal A.A. Histological and bioadhesion studies on buccal bioadhesive tablets containing a penetration enhancer sodium glycodeoxycholate. Int. J. Pharm. 170 (1998) 239-245
63. Shin S.-C., Kim J.-Y., and Oh I.-J. Mucoadhesive and physicochemical characterization of carbopol-poloxamer gels containing triamcinolone acetonide. Drug Develop. Ind. Pharm. 26 (2000) 307-312
64. Siegel I.A., and Gordon H.P. Effects of surfactants on the permeability of canine oral mucosa in vitro. Toxicol. Lett. 26 (1985) 153-157
65. Steward A., Bayley D.L., and Howes C. The effect of enhancers on the buccal absorption of hybrid (BDBB) alpha-interferon. Int. J. Pharm. 104 (1994) 145-149
66. +-induced contraction of rat intestine in vivo. Eur. J. Pharmacol. 96 (1983) 295-301
67. Tapolsky, W., Gilles, H., Osborne, D., 2000. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues. US Patent 6,103,266.
68. Ukai, K., Harada, T., 2003. Medicinal comparisons with relieved bitterness. US Patent 6,576,677.
69. Van Outryve M., Mayeur S., and Meeus M.A. A double blind, crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained-release in the treatment of irritable bowel syndrome. J. Clin. Pharm. Ther. 20 (1995) 277-282
70. Vaughan D. Predicting stability in rheologically modified systems. In: Laba D. (Ed). Rheological Properties of Cosmetics and Toiletries (1993), Marcel Dekker Inc., New York 371-401 (Chapter 9)
71. Yong C.H., Choi J.S., Quan Q.-Z., Rhee J.-D., Kim C.-K., Lim S.-J., Kim K.-M., Oh P.-S., and Choi H.-G. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int. J. Pharm. 226 (2001) 195-205
72. Zinner D.D., Duany L.F., and Lutz H.J. A new desensitizing dentifrice: preliminary report. J. Am. Dent. Assoc. 95 (1977) 982-990